ModuSystems delivers advanced motion control and automation solutions for customers who need speed, precision, and scalability. At the core is ModuLYNX, our unified motion platform that connects standardized hardware, intelligent controls, and AI-assisted configuration to eliminate one-off engineering and accelerate deployment. Proof of this concept is Quantyx, a precision liquid-handling automation solution designed for accuracy and repeatability. | ModuSystems is a manufacturer of Motion Controllers, Linear Actuators, and Custom Motion Systems. Systems and Controls are designed to be Modular and Easy to Program, while still meeting the most demanding challenges of multi-axis motion systems.
Mithrl
Mithrl is a Scientific Decision Engine that compresses the discovery loop for pharma and biotech R&D. With Mithrl’s enterprise-ready agentic AI systems, bench scientists and computational biologists can accelerate analyses and contextualize results with rigorous biological insights. Mithrl enables researchers to identify new therapeutic targets, discover new biomarkers, and understand mechanisms of action, moving from raw data to reproducible insights and defensible IP opportunities. Learn more at mithrl.com.
Miltenyi Biotec B.V. & Co. KG
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 4,500 employees in 28 countries.
MilliporeSigma
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is committed to advancing cancer research. Our extensive portfolio of over 300,000 products supports the development of novel therapies, diagnostics, and prevention strategies. We offer solutions across key areas, including molecular tools, sample preparation, antibodies, cell culture, live cell analysis, biochemicals, and biomarker immunoassays. Cancer research is a multidisciplinary effort, and we provide integrated tools that accelerate progress at every stage—from basic to clinical research. Our molecular tools allow researchers to study cancer’s genetic and molecular foundations, while our high-quality antibodies enable the detection of proteins involved in cancer progression. MilliporeSigma also offers advanced sample preparation technologies for analyzing DNA, RNA, and proteins from tumor samples, and live cell analysis platforms for real-time insights into cellular behaviors and drug responses. Our biomarker immunoassays help identify cancer biomarkers and monitor treatment efficacy, supporting the development of early detection tests and personalized medicine. We are dedicated to empowering researchers with innovative solutions that help advance cancer prevention, detection, and treatment. MilliporeSigma is your trusted partner in tackling cancer biology complexities, accelerating breakthroughs, and realizing a future where cancer is more treatable and preventable. | As a leading science and technology company, we uniquely combine three specialized, innovation-driven businesses: Life Science, Healthcare, and Electronics. We utilize our multi-industry expertise to address a wide spectrum of global challenges. By supplying advanced scientific research and biotechnological manufacturing products, developing therapies for serious diseases, and providing high-performance materials for semiconductors and displays, we contribute to improving health, scientific progress, and technology for people around the world. | MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. We are built to serve you in your drug development journey – as one trusted partner. Whether you need Millipore® CTDMO services, with decades of development, manufacturing, and testing expertise, to deliver a streamlined experience, or standalone industry-leading BioReliance® contract testing services and analytical development, we are built to serve you – to accelerate your milestones and breakthroughs. | MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, leverages over 35 years of CDMO experience and 75 years of contract testing services to redefine the industry CDMO model for today’s dynamic market needs. Our integrated Millipore® CTDMO Services offer expertise in development, manufacturing, contract testing, and technologies from pre-clinical to commercial stages, serving as a single experienced partner to accelerate your milestones and breakthroughs. With extensive experience in mRNA & LNP Formulation, ADC, Small Molecule, Biologics, and Viral Vector, we are dedicated to supporting your drug development journey as a trusted partner. Whether you seek a streamlined experience with a single partner or standalone industry-leading BioReliance® contract testing services and analytical development, we are committed to accelerating your milestones and breakthroughs while forging partnerships aimed at bringing breakthroughs to life to ultimately help patients. 2025 North America Advance Biotech Grant Award Ceremony Join us in the Start-up Stadium at 1:30pm, June 17th, to hear from our finalists and discover who will receive $258,000 in bioprocessing technologies, bioprocessing consulting services, contract testing services, and a full subscription to Emprove® Premium. The next round of applications will open in early 2026. | From the first spark of discovery to full-scale manufacturing, we stand beside you with the products, services, and expertise to help you move with speed and confidence. As a global leader in life science, MilliporeSigma supports innovators across biotech and pharma with 300,000+ products and comprehensive solutions all designed to help you progress from early research through process development, scale-up, and manufacturing. What you can explore with us: • Lab essentials and workflows to keep research moving day to day • Water purification systems for consistent lab performance • Raw and starting materials to support reliable manufacturing • Bioprocessing solutions and customized systems for your unique process needs • Ultrafiltration and downstream technologies to support scalable production • Contract testing and CDMO services to help you advance programs and meet quality requirements Whether you’re advancing a lead candidate, scaling a platform, or strengthening manufacturing readiness, we’ll connect you with experts who can help. | MilliporeSigma, the U.S. life science business of Merck KGaA, Darmstadt, Germany, partners with food safety teams to enable you to improve lab testing efficiencies with reliable products and services that meet ever changing regulations. It is through our collaborations that we can advance the safety and analysis of foods and beverages using trusted brands like Millipore® with microbiology solutions for hygiene, environmental monitoring & pathogen detection, Supelco® analytical solutions for analysis of food contamination and authenticity, Milli-Q® lab water solutions and Sigma Aldrich lab & production materials, including chemicals, inorganics & solvents throughout the supply chain, manufacturing and distribution. | MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany. MilliporeSigma’s portfolio spans more than 300,000 products enabling scientific discovery. MilliporeSigma has customers in life science companies, university and government institutions, hospitals and industry. More than 1 million scientists and technologists use its products. The company is committed to solving the toughest problems in life science by collaborating with the global scientific community. | MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany. With 19,000 employees and 72 manufacturing sites worldwide, MilliporeSigma’s portfolio spans more than 300,000 products enabling scientific discovery. MilliporeSigma has customers in life science companies, university and government institutions, hospitals and industry. More than 1 million scientists and technologists use its products. The company is committed to solving the toughest problems in life science by collaborating with the global scientific community. For more information, www.emdmillipore.com and www.sigma-aldrich.com.
Metware Biotechnology Inc.
Metware Biotechnology is a metabolomics research and technology CRO focusing on developing and applying innovative proteomics and metabolomics technologies to life science and health research. Using state of the art mass spectrometry as well as in-house library and database, our work have been cited in over 500 papers. Let us help you today.
Medicines Discovery Catapult
About Medicines Discovery Catapult Medicines Discovery Catapult (MDC) is a national Life Sciences service dedicated to turning drug discovery into commercial breakthroughs. At the frontier of drug discovery, MDC works with entrepreneurial scientists to make every move count. It validates their ideas, de-risks investments, and feeds insights back into the sector to drive productivity and impact. MDC creates momentum through its unique blend of discovery expertise, technology, insights, and sector-leading partnerships. Where there is unmet patient need, MDC stimulates innovation through its National Programmes. MDC has worked with over 380 organisations, who have gone on to raise more than £1.8bn of R&D investment. Its approach to drug discovery drives game-changing breakthroughs and improves patients’ lives. More information: Part of the Innovate UK Catapult Network Based in Alderley Park, Cheshire For more information, visit https://md.catapult.org.uk/
LuminoDx
At LuminoDx, we are dedicated to pushing the boundaries of precision medicine, leveraging our experience and expertise. We are paving the way in next-gen liquid biopsy analysis from exosome isolation to high content proteomics (Olink), comprehensive molecular testing and clinical assay development. By leveraging the power of liquid biopsy, we aim to increase precision medicines value for therapeutic development and patient treatment.
LMS Consult GmbH & Co. KG
LMS – your reliable partner for top-quality laboratory products For over 40 years, we have been the first port of call when it comes to high-quality laboratory products and reliable procurement solutions. With our in-depth knowledge of the market, a network of top manufacturers and a clear focus on efficiency, LMS offers you real added value. Our promise ✔ Access to leading brand products ✔ Top conditions thanks to strong purchasing partnerships ✔ Fast, smooth logistics – everything from a single source ✔ Personal advice and individual solutions Whether routine requirements or special products – we supply what you need. Our wide selection covers all requirements, and thanks to our direct connection to numerous manufacturers, we can also procure more specialized items quickly and reliably. LMS – Your advantage in purchasing. Your strength in the lab. Contact us now – we are here for you! LMS – for your best lab in the world
LG AI Research
LG AI is a pioneering research group in AI technology, active across business domains of LG group. We are particularly focused on conducting significant research within life sciences, healthcare, and drug discovery. Our Bio AI initiative focuses on integrating large-scale multimodal data with genomics, transcriptomics, pathology, spatial omics, and clinical information to accelerate scientific discovery and deliver practical value to biopharma partners.
LexigenBio
LexigenBio is a genomics technology company, dedicated to accelerating scientific discovery by breaking through critical bottlenecks in NGS workflows. Our integrated ecosystem combines the ultra-sensitive, single-day enrichment of LeXso for demanding applications from liquid biopsy to cell therapy QC, the scalable automation of LeXBot, and the advanced analytical power of our AI engine, LeXVerse. By providing a seamless and intelligent path from sample to insight, we empower our partners in academia and industry to advance translational research, develop novel diagnostics, and bring the next generation of precision medicine to reality faster.